Seminars in Nuclear Medicine
Volume 38, Issue 2 , Pages S30-S39 , March 2008

Patient-Specific Radiation Dosimetry for Radionuclide Therapy of Liver Tumors With Intrahepatic Artery Rhenium-188 Lipiodol

  • Pat B. Zanzonico, PhD

      Affiliations

    • Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY.
    • Corresponding Author InformationAddress reprint requests to Pat B. Zanzonico, PhD, Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021.
    • ,
  • Chaitanya Divgi, MD

      Affiliations

    • Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY.
    • Present address: Division of Nuclear Medicine, University of Pennsylvania, Philadelphia, PA.

References 

  1. Sgouros G. Treatment planning for internal emitter therapy: Methods, applications and clinical implications. In:  Schlafke-Stelson A,  Stabin M,  Sparks R editor. Proceedings of the Sixth International Radiopharmaceutical Dosimetry Symposium (ORISE 99-0164). Oak Ridge, TN: U.S. Dept of Energy and Oak Ridge Associated Universities; 1999;p. 13–25
  2. Zanzonico P, Brill A, Becker DV. Radiation dosimetry. In:  Wagner W,  Szabo Z,  Buchanan J editor. Principles of Nuclear Medicine. (ed 2). Philadelphia, PA: W.B. Saunders Co; 1995;p. 106–134
  3. Zanzonico P, Edwards C, Sgouros G, et al. Practical dosimetry: Quantitative imaging in radionuclide therapy. In:  Adelstein S,  Kassis AI,  Burt RW editor. Dosimetry of Administered Radionuclides. Washington, DC: American College of Nuclear Physicians/Department of Energy; 1989;p. 275–294
  4. Furhang EE, Larson SM, Buranapong P, et al. Thyroid cancer dosimetry using clearance fitting. J Nucl Med. 1999;40:131–136
  5. Benua R, Cicale N, Sonenberg M. The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer. Am J Roentgenol. 1962;87:171–182
  6. Kaminski MS, Zasadny KR, Francis IR, et al. Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody. N Engl J Med. 1993;329:459–465
  7. Kaminski MS, Zasadny KR, Francis IR, et al. Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma. J Clin Oncol. 1996;14:1974–1981
  8. Wahl RL, Zasadny KR, MacFarlane D, et al. Iodine-131 anti-B1 antibody for B-cell lymphoma: An update on the Michigan Phase I experience. J Nucl Med. 1998;39:21S–27S
  9. Zasadny K, Gates VL, Fisher SJ, et al. Correlation of dosimetric parameters with hematological toxicity after radioimmunotherapy of non-Hodgkin’s lymphoma with I-131 anti-B1 (Utility of a new parameter: “Total body dose-lean”). J Nucl Med. 1995;36:214P
  10. Weber D, Eckerman KF, Dillman LT, et al. MIRD: Radionuclide Data and Decay Schemes. In: New York: Society of Nuclear Medicine; 1989;p. 447
  11. Madsen MT, Park CH, Thakur ML. Dosimetry of iodine-131 ethiodol in the treatment of hepatoma. J Nucl Med. 1988;29:1038–1044
  12. Nakajo M, Kobayashi H, Shimabukuro K, et al. Biodistribution and in vivo kinetics of iodine-131 lipiodol infused via the hepatic artery of patients with hepatic cancer. J Nucl Med. 1988;29:1066–1077
  13. Sgouros G, Jureidini IM, Scott AM, et al. Bone marrow dosimetry: Regional variability of marrow-localizing antibody. J Nucl Med. 1996;37:695–698
  14. Siegel J, Wessels BW, Watson EE, et al. Bone marrow dosimetry and toxicity in radioimmunotherapy. Antibody Immunocon Radiopharm. 1990;3:213–223
  15. Sgouros G. Bone marrow dosimetry for radioimmunotherapy: Theoretical considerations. J Nucl Med. 1993;34:689–694
  16. Snyder W, Ford MR, Warner GG, et al. Estimates of absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom (Medical Internal Radiation Dose (MIRD) Pamphlet No 5). J Nucl Med. 1969;10(suppl 3):5–52
  17. Cristy M, Eckerman K. Specific absorbed fractions of energy at various ages from internal photon sources (I-VII) (Oak Ridge National Laboratory Report ORNL/TM-8381/V1-7). Springfield, VA: National Technical Information Service, Dept of Commerce; 1987;
  18. Zanzonico PB, Bigler RE, Sgouro G, et al. Quantitative SPECT in radiation dosimetry. Semin Nucl Med. 1989;19:47–61
  19. Jaszczak R, Greer RJ, Floyd CE, et al. Improved SPECT quantitation using compensation for scattered photons. J Nucl Med. 1984;25:893–900
  20. Loevinger R, Budinger TF, Watson EE, et al. MIRD Primer for Absorbed Dose Calculations. New York: Society of Nuclear Medicine; 1991;
  21. Snyder W, Ford MR, Warner GG, et al. “S,” Absorbed Dose Per Unit Cumulated Activity for Selected Radionuclides and Organs (Medical Internal Radiation Dose (MIRD) Pamphlet No 11). New York: Society of Nuclear Medicine; 1975;
  22. Zanzonico PB. Internal radionuclide radiation dosimetry: A review of basic concepts and recent developments. J Nucl Med. 2000;41:297–308
  23. Marinelli L, Quimby E, Hine G. Dosage determination with radioactive isotopes (I. Fundamental dosage formulae). Nucleonics. 1948;2:56–66

 Conflict of Interest: None.

PII: S0001-2998(07)00121-3

doi: 10.1053/j.semnuclmed.2007.10.005

Seminars in Nuclear Medicine
Volume 38, Issue 2 , Pages S30-S39 , March 2008

Article Tools

* Image Usage & Resolution